Home > Corporate Profile
Since 1951, Jinxin Reproductive has developed into a leading assisted reproductive service organization in China and the United States, and continues to expand our network to provide more and more high-end services of higher value. The group includes five centers of assisted reproductive technology: Chengdu Xi Nan, Shenzhen Zhongshan, Wuhan Jinxin, HRC Fertility and Jinrui Medical Center.
The establishment of the Group dates back to 2003, when a team of senior and dedicated doctors and managers agreed to set up Jinjiang IVF Center in Chengdu, Sichuan Province to focus on assisted reproductive services and related treatments. Shenzhen zhongshan hospital was founded in May 2004 by a number of personal founders including Mr Zeng yong, one of our senior management members. Shenzhen Zhongshan Hospital provides assisted reproduction and other complementary medical services and assisted in the birth of the first baby in Shenzhen through IVE-ET technology and IVF combined with ICSI technology.
According to Frost Sullivan Report, our in-network assisted reproductive care facilities in China ranked third in the assisted reproductive services market in China in 2018, performing 20,958 cycles of external fertilization (" IVF "), with a market share of about 3.1%. According to the same index, the agency also ranked first among non-state assisted reproductive service institutions in China in 2018.
Through the acquisition of HRC Management, which manages HRC Medical, HRC Fertility has enhanced our ability to provide high-value assisted reproductive services to international patients, particularly those from China. HRC Fertility is a leading full-service assisted reproductive service in the United States with over 30 years of experience. In addition to the similar IVF services we provide in China, we also provide pre-implantation genetic screening (" PGS ") services and pre-implantation genetic diagnosis (" PGD ") services through third party clinics or institutions. HRC Fertility ranked first among all assisted reproductive service providers in the United States in terms of IVF treatment cycles for Chinese outbound assisted reproductive service patients traveling to the United States for treatment in 2017.
The Brand's Four 'Tops' in Industry
The World-leading Brand and the Industrial Benchmark
Jinxin Fertility Specializes in ART Related Service and Treatment
Jinxin Fertility ranked No.1 in ARS market in Sichuan Province, Shenzhen and the West Coast of the United States in 2019, and performed 27,854 IVF cycles
International Quality and the Largest Nationwide VIP Medical Service System
HIGH SUCCESS RATE